Glezer, Stanislav
Hess, Michael W.
Kamada, Alan K.
Funding for this research was provided by:
Inogen, Inc.
Article History
Received: 14 December 2023
Accepted: 12 January 2024
First Online: 7 February 2024
Declarations
:
: Dr. Stanislav Glezer is an employee and shareholder of Inogen Inc. Mr. Michael W Hess is an employee of the COPD Foundation and serves as a member of an Advisory Board and is a paid consultant for Inogen Inc. Dr. Alan K. Kamada is an employee of Inogen Inc.
: This analysis meets the exemption criterion of section 45 CFR 46 ยง46.104 (8), thus IRB approval was not required. A limited review of the study was conducted by WGC IRB LLC who determined that the research was conducted within the scope of the broad consent referenced in paragraph (d)(8)(i) of the corresponding section of the CFR.